No Prescription |
 |
 | ||
|
Maxolon Clopra |
|
| ||
No Prescription » Prescription Drugs 10 » Maxolon Clopra Metoclopramide is used to relieve nausea and vomiting; heartburn stomach pain and bloating; and a persistent feeling of fullness after meals.Metoclopramide is an antisickness medicine though it also has other uses due to its action on the gut.Metoclopramide can also be used to restore normal muscle tone and function to the gut following surgery and in various digestive disorders. This helps relieve symptoms such as indigestion pain bile regurgitation flatulence acid reflux and heartburn.In adults over 20 years of age metoclopramide is used for the following conditions:nausea and vomiting due to digestive disorders anti-cancer chemotherapy heart failure deep X-ray or cobalt therapy and following general anaesthetics relief of digestive symptoms such as indigestion heartburn flatulence sickness bile regurgitation and stomach pain due to conditions such as peptic ulcer hiatus hernia gallstones reflux oesophagitis or inflammation of the stomach or small intestine (gastritis or duodenitis)relieving nausea and vomiting and assisting the absorption of painkillers in migraine to assist hospital investigative procedures on the gut (eg barium meal duodenal intubation)to help restore normal stomach emptying after surgery.Use in patients under 20 years of age is restricted to the following conditions:severe persistent vomiting where the cause is knownvomiting due to chemotherapy or radiotherapyas an aid to hospital investigative procedures on the gut (gastro-intestinal intubation)as part of a pre-med before an operation to prevent nausea and vomiting. Buy Maxolon Clopra and other Prescription Drugs 10 products online at Medstore. 178
About Maxolon Clopra: Product Type: Prescription Drugs 10 Maxolon ( Clopra Octamide Reglan Generic Metoclopromide ) Maxolon (Clopra Octamide Reglan Generic Metoclopromide) Clopra Octamide Reglan Generic Metoclopromide 10mg 100 tabs Clopra Octamide Reglan Generic Metoclopromide Maxolon
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
